ACN vs DOX: Which Is the Better Buy in 2026?
Last updated November 2026
Short answer
ACN is the larger of the two ($149.81B market cap): the incumbent the market prices for continued execution (15.96x forward earnings, beta 1.00). DOX is the smaller challenger ($4.18B), cheaper on forward earnings (6.04x): more room to run, but more to prove. The real question is which set of drivers you believe, and whether owning one (or both) leaves you over-concentrated.
ACN vs DOX: the tie-breaker metrics
Same yardstick, side by side (as of November 2026). Valuation lined up like this is most meaningful for two names in the same corner of the market, which these are. Figures are approximate; verify before investing.
| Metric | ACN | DOX | What it tells you |
|---|---|---|---|
| Market cap | $149.81B | $4.18B | Size. The larger name is the incumbent; the smaller has more room to grow and more to prove. |
| Forward P/E | 15.96 | 6.04 | Valuation on next year's expected earnings, the same yardstick for both. Lower is cheaper for that growth; higher means the market is paying up. |
| Trailing P/E | 18.70 | 8.55 | Valuation on the last 12 months. A big drop from trailing to forward means the market expects earnings to jump, so more growth is already in the price. |
| Beta | 1.00 | 0.41 | Volatility vs the market. Above 1 swings harder than the index; below 1 is steadier. Higher beta means bigger drawdowns to hold through. |
| Price vs 52-week range | 78% of range | 0% of range | Where today's price sits between the 52-week low and high. Near the high is momentum with less margin of safety; near the low is out of favor or a discount, depending on why. |
| Price / book | 4.78 | 1.26 | How much you pay over book value. Very high can signal an asset-light, high-return business or a rich price. |
Reading it: DOX is the cheaper of the two on forward earnings, but cheaper is not the same as better. Pair the valuation with growth (how far the forward P/E sits below the trailing P/E) and risk (beta) before you decide.
Before you buy: how ACN and DOX affect your concentration
The metrics above tell you which is the marginally better business. The bigger risk for most people is not picking the slightly worse stock, it is over-concentrating. ACN and DOX share themes, so owning both, or adding either to what you already hold, can quietly push a large share of your portfolio into one bet.
This is the part a generic comparison page cannot answer, because it depends on what you own. Connect your brokerage and Walnut shows your real, combined ACN and DOX exposure, flags overlap with your existing positions, and tells you if adding one would tip you past a concentration you are comfortable with, read-only by default, with your login staying at your broker. Walnut is not an investment adviser.
What does Accenture (ACN) do?
Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. The company operates across five major service areas: Strategy and Consulting, Technology Services, Operations, Industry X (engineering and manufacturing digitization), and Song (marketing and customer experience). It earns revenue through a mix of consulting engagements, managed services contracts, and increasingly fixed-price, outcome-based arrangements, with managed services growing faster at roughly 10% year over year as of Q2 FY2026. The company serves clients in virtually every major industry vertical, from financial services and health to communications and government, and generates the majority of its revenue outside North America.
What does Amdocs (DOX) do?
Amdocs Limited builds and operates the software that communications and media companies use to sell, bill and support their services. Its products sit in what the industry calls BSS and OSS: customer care, product catalogs, charging and billing, and order management on the commercial side, plus network orchestration, provisioning and service assurance on the operations side. Most of the revenue no longer comes from selling licenses. It comes from managed services, where Amdocs staff run those systems inside the carrier's own environment under multi-year contracts, a line that reached a record $791 million, or 67% of sales, in the June 2026 quarter. The rest is systems integration and cloud migration, the slow work of lifting decades-old on-premise stacks onto AWS, Azure and Google Cloud. Customers include AT&T, T-Mobile US, Vodafone, Telefonica's Vivo, Comcast, Lumen, Sunrise, Liberty Latin America and, since October 2026, VEON under a ten-year modernization agreement. On October 8, 2026 Amdocs completed the sale of Vubiquity, its media supply chain and content licensing business, to Premiere Digital for undisclosed terms; management said the divestiture sharpens its focus on its new agentic strategy. The company was founded in Israel in 1982, is incorporated in Guernsey, runs its main operating centers in Ra'anana and in Chesterfield, Missouri, employs roughly 27,000 people, and closes its fiscal year on September 30.
ACN vs DOX: how do they differ?
Both fit overlapping themes, but they are not interchangeable. The useful comparison is which set of drivers and risks you want exposure to.
- ACN drivers: Enterprise AI implementation at scale; Shift to recurring, outcome-based revenue.
- DOX drivers: Managed services turned a project vendor into an annuity; Cash return is carrying the load the growth rate is not.
Which fits which kind of investor
A faster-growing, richer-valued name usually swings harder, so it suits a longer horizon and a higher tolerance for volatility; a steadier, more cash-generative business suits a more conservative or income-minded investor. A useful test is which set of risks you could hold through a drawdown: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. For DOX, customer concentration is the structural risk: AT&T has accounted for roughly a quarter of revenue in recent years and T-Mobile US is the next largest, so one carrier's budget decision moves the whole income statement, and management has already said it expects T-Mobile revenue to decline in fiscal 2026 as non-recurring work winds down.
ACN or DOX: which should you pick?
Growth-minded investors who believe the theme has years to run tend to accept the richer multiple for more upside; value-minded investors lean toward the cheaper forward earnings and steadier profile. Pick ACN if you believe its drivers more; DOX if you believe its. Many investors hold both, but since they share themes, that is a concentrated bet, not diversification. Decide deliberately and check overlap. For the full detail, see the ACN and DOX guides.
ACN vs DOX: the full fundamentals
ACN. At ~$227.69 on October 16, 2026, Accenture trades at about 16.8x trailing earnings and ~14.3x forward estimates, up from roughly 10 to 13x in June after a ~62% three-month rally, though still below its 5-year average near 25x. Consensus calls for fiscal 2027 EPS of ~$14.66 on ~$77.4 billion of revenue, and trailing free cash flow of ~$11.2 billion covers the dividend (about a 51% payout ratio) and buybacks. The next report, for the quarter ending November 30, is scheduled for December 17, 2026.
DOX. At about $60 a share, DOX trades near 14 times trailing GAAP earnings and roughly 7.5 times forward non-GAAP earnings, a multiple usually reserved for businesses the market expects to shrink. Much of the gap between those two figures is the $106 million restructuring charge taken in the June quarter, which weighed on GAAP results without changing the cash flow guidance. The stock has recovered part of its 2026 slide since July, but whether the discount is deserved depends less on any single quarter's revenue than on whether the 12-month backlog keeps renewing at current margins.
Headline figures (approximate, October 2026): ACN shows revenue (fy2026, ended aug 31 2026) ~$74.2 billion (+~6.5% YoY), q4 fy2026 revenue ~$18.7 billion (+~6.2% YoY), q4 fy2026 eps ~$3.29 (vs ~$3.18 consensus), net income (fy2026) ~$8.4 billion (~11.3% net margin); DOX shows revenue (ttm) ~$4.65 billion, revenue (q3 fy2026) ~$1.17 billion, up ~2.7% year over year, non-gaap diluted eps (q3 fy2026) ~$1.84, in line with estimates, margins (ttm) ~38% gross, ~18% operating, ~10% net.
The bottom line: ACN vs DOX
ACN and DOX are related but distinct: same themes, different businesses and risks. Neither wins in the abstract; the right pick is whichever thesis you actually believe, sized so you are not over-concentrated in one theme. Walnut can show your combined ACN and DOX exposure against your real portfolio. It is not an investment adviser.
Wondering how ACN or DOX fits the portfolio you already own? Walnut is an AI investing app that connects your brokerage read-only and answers questions like that about your actual holdings: overlap, concentration, and how each position tracks the S&P 500. Compare the best AI portfolio analyzers or see the best AI investing apps in 2026.
Your questions about Accenture
Ask Walnut's AI anything about ACN and see how it fits what you own.
FAQ
What is the difference between ACN and DOX?
+
Accenture is a global professional services company that helps businesses, governments, and other organizations across more than 120 countries build digital infrastructure, optimize operations, and accelerate growth. Amdocs Limited builds and operates the software that communications and media companies use to sell, bill and support their services. They show up together because they share investment themes, but they are different businesses, so the better fit depends on which thesis you are expressing.
Is ACN or DOX the better stock?
+
Neither is universally better. ACN is the larger incumbent; DOX is the smaller challenger and looks cheaper on forward earnings. Walnut is informational, not investment advice. Compare what each does, the tie-breaker metrics above, and the risks, then decide which fits your thesis and what you already own.
Which is cheaper, ACN or DOX?
+
On forward P/E (as of November 2026), ACN trades at 15.96x and DOX at 6.04x, so DOX is the cheaper of the two on next year's expected earnings. A lower multiple is not automatically the better buy: a richer valuation can be justified by faster growth, and a lower one can reflect real risk. Weigh the multiple against how fast each business is compounding.
Should you own both ACN and DOX?
+
Because they share themes, owning both concentrates you in that theme. That can be intentional (a focused bet) or accidental (less diversification than it looks). Walnut can show your combined exposure across both, and whether adding either over-concentrates you, before you buy.
What are the risks of ACN vs DOX?
+
ACN: The most structural bear-case concern is AI cannibalization: if generative AI and agentic AI tools automate the coding, testing, documentation, and process management that make up a significant portion of Accenture's billable work, clients may require fewer hours per engagement, compressing revenue without a commensurate reduction in costs. Accenture is also exposed to a slowdown or outright contraction in U.S. federal government spending, as DOGE-driven budget cuts have already created headwinds in its government and public services segment. Additionally, the broader macroeconomic environment and client caution around large discretionary IT spending create near-term bookings softness, which prompted multiple analyst price target reductions earlier in 2026. After the ~62% three-month rally, the stock trades just above the ~$225 mean analyst target, so expectations have reset higher, and a larger acquisition program (~$8 billion planned for fiscal 2027) adds integration and regulatory-timing risk. Finally, foreign currency fluctuations across more than 120 countries add meaningful volatility to reported results, since the majority of revenue is earned outside the United States. DOX: Customer concentration is the structural risk: AT&T has accounted for roughly a quarter of revenue in recent years and T-Mobile US is the next largest, so one carrier's budget decision moves the whole income statement, and management has already said it expects T-Mobile revenue to decline in fiscal 2026 as non-recurring work winds down. The second risk is the one the market is currently pricing, that agentic AI turns a large pool of billable human delivery into something customers expect to pay far less for, which would show up as repricing at contract renewal rather than as a sudden revenue drop. Growth is already slow at 2.7% in the latest quarter, which leaves almost no cushion if a large renewal comes in smaller, and the Vubiquity sale will take a slice of revenue out of future comparisons. GAAP earnings are under pressure too: June-quarter net income fell to about $62 million, and trailing net income of about $456 million is down sharply from a year earlier. Telecom consolidation cuts both ways, since a merger can create a large integration project or eliminate a customer entirely. Currency swings and the concentration of engineering staff in Israel add operational exposure that a purely US-domiciled peer would not carry, and the $106 million restructuring charge is a reminder that reshaping the cost base is neither free nor finished.
Walnut is informational, not investment advice. This page is descriptive and not a recommendation to buy or sell ACN or DOX; figures are approximate and dated (as of November 2026). Verify current data before investing.